Group 1: Financial Performance - In the first half of 2024, the company achieved a revenue of 32,238.50 million CNY, a year-on-year decrease of 13.22% [2] - The net profit attributable to shareholders, after deducting non-recurring gains and losses, was 4,752.13 million CNY, reflecting a year-on-year increase of 2.58% [2] - Sales revenue from the key customer, Chongqing Xinjing, for nano-microcrystalline glass products decreased by 54.65% compared to the same period last year [3] Group 2: Research and Development - R&D expenses for the first half of 2024 amounted to 2,604.19 million CNY, an increase of 67.09% year-on-year [3] - The company has 123 R&D personnel and is currently undertaking 15 projects, with 6 new invention patents added [3] - The R&D center has acquired 29 sets of advanced testing equipment and increased testing projects by 18 [4] Group 3: Business Expansion - The company is expanding its nano-microcrystalline glass business by leveraging its own technology, patents, and market advantages [5] - In the first half of 2024, the company completed the R&D and trial production of proprietary microcrystalline glass products and is actively pursuing customer product certification and business cooperation [5] Group 4: Future Development Plans - The company plans to enhance R&D capabilities by building a high-end talent team and developing a technology innovation platform for glass materials [6] - It aims to continuously improve product formulations and mass production processes to meet various performance demands in downstream applications [6] - The company will focus on launching new products in the optical glass sector and strengthening the industrial chain layout in the nano-microcrystalline glass field [6]
戈碧迦(835438) - 投资者关系活动记录表